SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : WASP (Wasatch Pharmaceutical about to come out...)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ed Hoftell who wrote (28)10/24/1997 6:43:00 PM
From: Frank Fontaine  Read Replies (1) of 36
 
Thanks Ed, Heres the whole news release.
MIDVALE, Utah--(BUSINESS WIRE)--Oct. 24, 1997--Wasatch Pharmaceutical Inc., a Utah corporation (OTC BB: WASP) announced in April, 1997 that it was extending its clinical trials on a new therapy for the treatment of folliculitis, a serious condition in which the patient has ingrown hairs to the extreme. This condition effects persons of all ages, and is especially prevalent with adult males within the population of those with dark skin.

The number of patients targeted for this study is sixty. To date, twenty-three patients have been treated with only one patient not responding to therapy. This represents a 96% success rate with no reason to believe that this success rate will not hold up through the remainder of the clinical trials. This will represent a major breakthrough for a serious skin condition affecting millions of people both children and adults.

Once the trials are completed, Wasatch will make application with the FDA for over-the-counter approval. Because Wasatch owns its own medical clinics, it will now begin to promote within these clinics the treatment of folliculitis to the general public. The goal of three hundred company-owned clinics over the next five years will afford us the opportunity to impact the marketplace both within our own clinics and the OTC market as we develop over-the-counter products for other skin conditions we now treat along with folliculitis.

CONTACT: Wasatch Pharmaceutical Inc., Midvale
Dave Giles, 801/566-9688
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News